| 1-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]-2-fluoroethanone | IC50 | 15.0 [1] |
| [(2S,3S,4S,5R,6S)-4-Acetyloxy-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-5-hydroxy-2-methyloxan-3-yl] acetate | IC50 | 89.0 [1], 370.0 [2], 583.0 [3], 990.0 [4] |
| N-(1-Methylbenzimidazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 9.0 [1], 200.0 [2] |
| N-(3-Methyl-1,2-oxazol-5-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 19.0 [1], 200.0 [2] |
| N-(1-Methylpyrazol-4-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 11.0 [1], 790.0 [2] |
| 2,6-Difluoro-4-[4-(4-morpholin-4-ylphenyl)pyridin-3-yl]phenol | IC50 | 4.0 [1], 210.0 [2] |
| 4,4'-(1h-Pyrazole-3,4-Diyl)diphenol | IC50 | 20.0 [1], 24.0 [2], 2800.0 [3] |
| 2,6-Difluoro-4-{4-[4-(4-Methylpiperazin-1-Yl)phenyl]pyridin-3-Yl}phenol | IC50 | 5.0 [1], 340.0 [2] |
| 3-(4-Amino-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-7-yl)propan-1-ol | IC50 | 430000.0 [1], 1200000.0 [2], 30000000.0 [3] |
| CID 53246941 | IC50 | 1.0 [1], 20.0 [2] |
| 1-Oxo-N-pyridin-3-yl-3,4-dihydro-2H-pyrazino[1,2-a]indole-7-carboxamide | IC50 | 730.0 [1], 10000.0 [2] |
| 1-Oxo-N-pyridin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 240.0 [1], 1940.0 [2] |
| 4-Methyl-1-oxo-N-pyridin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 1200.0 [1], 4890.0 [2] |
| 3-(2-Furylmethylene)-1,3-dihydro-2H-indol-2-one | IC50 | 3470.0 [1], 7760.0 [2] |
| 4-Methyl-1-oxo-N-pyridin-3-yl-3,4-dihydro-2H-pyrazino[1,2-a]indole-7-carboxamide | IC50 | 170.0 [1], 1630.0 [2] |
| 4-[4-(4-Methylpiperazin-1-yl)phenyl]-5-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine | IC50 | 240.0 [1], 2400.0 [2] |
| 2,6-Difluoro-4-[4-(4-morpholin-4-ylphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]phenol | IC50 | 2.0 [1], 50.0 [2] |
| 5-(3,5-Difluoro-4-methoxyphenyl)-4-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridine | IC50 | 500.0 [1], 20000.0 [2] |
| 5-[4-(Difluoromethyl)phenyl]-4-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridine | IC50 | 800.0 [1], 18100.0 [2] |
| 2,6-Difluoro-4-[4-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]phenol | IC50 | 0.3 [1], 54.0 [2] |
| 2,6-Difluoro-4-[4-(4-methylphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]phenol | IC50 | 2.0 [1], 232.0 [2] |
| 5-(3,5-Difluorophenyl)-4-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridine | IC50 | 38.0 [1], 6000.0 [2] |
| 5-[4-[4-(4-Methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]pyridin-2-amine | IC50 | 810.0 [1], 7200.0 [2] |
| 5-(2-Fluoropyridin-4-yl)-4-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridine | IC50 | 1100.0 [1], 20000.0 [2] |
| 5-(4-Fluorophenyl)-4-[4-(4-methylpiperazin-1-yl)phenyl]-1H-pyrrolo[2,3-b]pyridine | IC50 | 1900.0 [1], 20000.0 [2] |
| 4,4-Dimethyl-1-oxo-N-pyridin-3-yl-2,3-dihydropyrazino[1,2-a]indole-7-carboxamide | IC50 | 210.0 [1], 1550.0 [2] |
| N-(1-Ethylbenzimidazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 1.0 [1], 40.0 [2] |
| N-(6-Chloro-1-ethylbenzimidazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 12.0 [1], 90.0 [2] |
| 1-Oxo-N-[1-(pyridin-4-ylmethyl)pyrazol-4-yl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 2.0 [1], 90.0 [2] |
| (5S)-N-[1-[3-(Dimethylamino)propyl]benzimidazol-2-yl]-5-methyl-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 14.0 [1], 100.0 [2] |
| N-(1H-Benzimidazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 4.0 [1], 10000.0 [2] |
| (3Z)-3-[[5-(2-Nitrophenyl)-1H-pyrazol-4-yl]methylidene]-1H-indol-2-one | IC50 | 1.6 [1], 500.0 [2] |
| (3S,4R)-3,4-Dimethyl-1-oxo-N-pyridin-3-yl-3,4-dihydro-2H-pyrazino[1,2-a]indole-7-carboxamide | IC50 | 45.0 [1], 840.0 [2] |
| 1-Oxo-N-(1-propan-2-ylpyrazolo[3,4-b]pyridin-5-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 53.0 [1], 840.0 [2] |
| 1-Oxo-N-(3-phenyl-1,2-oxazol-5-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 86.0 [1], 360.0 [2] |
| 1-Oxo-N-phenyl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 290.0 [1], 1930.0 [2] |
| N-(2-Carbamoylphenyl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 21.0 [1], 560.0 [2] |
| 1-Oxo-N-quinolin-2-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 68.0 [1], 1130.0 [2] |
| N-[6-Chloro-1-[3-(dimethylamino)propyl]benzimidazol-2-yl]-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 20.0 [1], 160.0 [2] |
| N-(1H-Imidazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 26.0 [1], 290.0 [2] |
| N-(1,3-Benzoxazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 367.0 [1], 10000.0 [2] |
| N-(5-Chloro-1-ethylbenzimidazol-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 6.0 [1], 130.0 [2] |
| N-[1-(Cyclohexylmethyl)pyrazol-4-yl]-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 7.0 [1], 120.0 [2] |
| 1-Oxo-N-pyridin-4-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 34.0 [1], 620.0 [2] |
| 1-Oxo-N-(1H-pyrazol-4-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 43.0 [1], 10000.0 [2] |
| 1-Oxo-N-quinolin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 34.0 [1], 340.0 [2] |
| 1-Oxo-N-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 10.0 [1], 460.0 [2] |
| N-(3-Cyclopropyl-1,2-oxazol-5-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 18.0 [1], 250.0 [2] |
| N-[1-[3-(Dimethylamino)propyl]benzimidazol-2-yl]-4,4-dimethyl-1-oxo-3,5-dihydro-2H-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 27.0 [1], 290.0 [2] |
| 1-Oxo-N-(1-propan-2-ylbenzimidazol-2-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 20.0 [1], 180.0 [2] |
| 1-Oxo-N-(1-phenylbenzimidazol-2-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 61.0 [1], 1000.0 [2] |
| N-(3-Ethylimidazo[4,5-b]pyridin-2-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 4.0 [1], 80.0 [2] |
| 1-Oxo-N-(3-propan-2-yl-1,2-oxazol-5-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 26.0 [1], 460.0 [2] |
| N-(3-Benzyl-1,2-oxazol-5-yl)-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 13.0 [1], 130.0 [2] |
| 5-Methyl-1-oxo-N-pyridin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 41.0 [1], 890.0 [2] |
| 1-Oxo-N-pyridin-2-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 220.0 [1], 2630.0 [2] |
| 1-Oxo-N-(pyridin-3-ylmethyl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 10000.0 [1] |
| N-[1-[3-(Dimethylamino)propyl]benzimidazol-2-yl]-1-oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 21.0 [1], 200.0 [2] |
| 2-[(Z)-[2-Bromo-6-(4-nitrophenyl)imidazo[2,1-b][1,3]thiazol-5-yl]methylideneamino]guanidine | IC50 | 607.1 [1], 1230.0 [2] |
| Staurosporine | IC50 | 0.5 [1] |
| Sunitinib | IC50 | 183.9 [1] |
| Dasatinib | IC50 | 20000.0 [1] |
| Tofacitinib | IC50 | 10000.0 [1] |
| Bisindolylmaleimide IX | IC50 | 10.0 [1] |
| (5Z)-5-(Quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one | Ki | 2000.0 [1] |
| 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | IC50 | 1.0 [1] |
| A-674563 | Ki | 580.0 [1] |
| JNK Inhibitor V | IC50 | 10000.0 [1] |
| JNK Inhibitor VIII | Ki | 7400.0 [1] |
| CID 59604787 | IC50 | 10000.0 [1] |
| (1S,2S,3R,4R)-3-[[5-Chloro-2-[[(7S)-4-methoxy-7-morpholin-4-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide | IC50 | 13.0 [1] |
| 2-[Ethyl-[[5-[[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-1,2-thiazol-3-yl]methyl]amino]-2-methylpropan-1-ol | IC50 | 180.0 [1] |
| 2-Amino[1,3]thiazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione | IC50 | 9990.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 7400.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 7400.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 7368.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| Khk-IN-1 | IC50 | 40000.0 [1] |
| 1-Oxo-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 9100.0 [1] |
| Tert-butyl N-[3-[3-[4-(2-methoxyphenyl)-2,5-dioxopyrrol-3-yl]pyrrolo[2,3-b]pyridin-1-yl]propyl]carbamate | IC50 | 640.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 7400.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 7400.0 [1] |
| 2-(4-Aminophenyl)-4-methyl-1H-benzo[d]imidazol-5-amine | IC50 | 320.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 3300.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 7400.0 [1] |
| (13R,15S)-13-Methyl-16-oxa-8,9,12,22,24-pentazahexacyclo[15.6.2.16,9.112,15.02,7.021,25]heptacosa-1(24),2,4,6,17,19,21(25)-heptaene-23,27-dione | IC50 | 1000.0 [1] |
| N-Propyl-4-({4-[(2,2,2-trifluoroethyl)amino]-1H-pyrrolo[2,3-d]pyrimidin-2-yl}amino)benzamide | IC50 | 83.0 [1] |
| (E)-Methyl 3-(4-amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)acrylate | IC50 | 250.0 [1] |
| 3-Methyl-N-[6-methylsulfanyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine | IC50 | 1306.0 [1] |
| N-[6-Methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-3-(piperidin-1-ylmethyl)-1,2-thiazol-5-amine | IC50 | 360.0 [1] |
| 2-((4-Morpholinophenylamino)methyl)isoindoline-1,3-dione | IC50 | 950.0 [1] |
| 3-Methyl-1-oxo-N-pyridin-3-yl-3,4-dihydro-2H-pyrazino[1,2-a]indole-7-carboxamide | IC50 | 350.0 [1] |
| 1-Oxo-N-(1,3-thiazol-2-yl)-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 2200.0 [1] |
| 4-(Aminomethyl)-1-oxo-N-pyridin-3-yl-2,3,4,5-tetrahydro-[1,4]diazepino[1,2-a]indole-8-carboxamide | IC50 | 1800.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| 5-(2-Aminoethyl)-7-(7-(benzo[b]thiophen-2-yl)-1H-indazol-5-yl)-5H-pyrrolo[3,2-d]pyrimidin-2-amine | IC50 | 4000.0 [1] |
| 3-[(1R)-1-[(2S,6R)-2,6-Dimethylmorpholin-4-yl]ethyl]-N-[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine | IC50 | 330.0 [1] |
| Tert-butyl (E)-3-[4-amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)pyrrolo[2,3-d]pyrimidin-6-yl]-2-cyanoprop-2-enoate | IC50 | 7.0 [1] |
| (E)-3-[4-Amino-7-(3-hydroxypropyl)-5-(4-methylphenyl)pyrrolo[2,3-d]pyrimidin-6-yl]-2-cyano-N-propan-2-ylprop-2-enamide | IC50 | 5.0 [1] |
| (E)-3-(4-Amino-7-(3-hydroxypropyl)-5-p-tolyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)acrylonitrile | IC50 | 750.0 [1] |